Final height and body mass index after fractionated total body irradiation and allogeneic stem cell transplantation in childhood leukemia

Pediatric Hematology and Oncology
Fernand FreyconJean-Louis Stephan

Abstract

Impaired linear growth has been reported in patients treated during childhood with allogeneic stem cell transplantation and fractionated total body irradiation (fTBI). The objective of this study was to determine the final height and body mass index (BMI) achieved. Forty-nine patients with leukemia were included and surveyed for more than 5 years. Median age at follow-up was 24.3 years (range, 18.9-35.8) and median follow-up time from allograft was 14.4 years (range, 4.5-21.9). Mean height standard deviation score (s.d.s.) at final examination (-1.1 ± 1.3,) was significantly lower than at fTBI (0.3 ± 1.2; P = .001). Final height s.d.s. was significantly correlated with age at diagnosis, age at fTBI, and target height (P = .001; P < .001; P < .001, respectively). Final height was significantly lower in children transplanted before age 5 (P = .006). Growth hormone treatment (n = 6) had only a modest effect on growth velocity. Mean BMI at follow-up was normal at 19.6 kg/m(2) for boys and 21.2 for girls, but with a significant decrease since allograft only for boys (-1.2 ± 1.5 s.d.s.) (P = .003). In conclusion, final height is decreased; BMI is normal but decreased from fTBI in boys.

References

Sep 1, 1992·Archives of Disease in Childhood·A L Ogilvy-StuartM D Donaldson
May 1, 1995·Archives of Disease in Childhood·A D Leiper
Jun 15, 1995·International Journal of Radiation Oncology, Biology, Physics·M C BenyunesR Witherspoon
Jul 31, 2001·Bone Marrow Transplantation·K NysomC Mølgaard
Aug 1, 2006·Bone Marrow Transplantation·A-C Couto-SilvaR Brauner
Sep 25, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Thomas LoweGeorge Somlo
Aug 18, 2009·Bone Marrow Transplantation·A-C Couto-SilvaR Brauner
Aug 25, 2009·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Pascal PommierChristian Carrie

❮ Previous
Next ❯

Citations

May 11, 2020·Journal of Cancer Survivorship : Research and Practice·Ava LorencUNKNOWN CTYA HSCT Adipose and Muscle Late Effects Working Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.